Cellectis Change To Netincome from 2010 to 2025

CLLS Stock  USD 1.30  0.01  0.76%   
Cellectis Change To Netincome yearly trend continues to be comparatively stable with very little volatility. Change To Netincome will likely drop to about 5.1 M in 2025. From the period from 2010 to 2025, Cellectis Change To Netincome quarterly data regression had r-value of (0.52) and coefficient of variation of  96.01. View All Fundamentals
 
Change To Netincome  
First Reported
2012-12-31
Previous Quarter
-12.2 M
Current Value
-12.2 M
Quarterly Volatility
18.2 M
 
Yuan Drop
 
Covid
Check Cellectis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cellectis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 20.8 M, Interest Expense of 7.8 M or Selling General Administrative of 29.7 M, as well as many indicators such as Price To Sales Ratio of 3.47, Dividend Yield of 0.0 or PTB Ratio of 1.1. Cellectis financial statements analysis is a perfect complement when working with Cellectis Valuation or Volatility modules.
  
Check out the analysis of Cellectis Correlation against competitors.

Latest Cellectis' Change To Netincome Growth Pattern

Below is the plot of the Change To Netincome of Cellectis SA over the last few years. It is Cellectis' Change To Netincome historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cellectis' overall financial position and show how it may be relating to other accounts over time.
Change To Netincome10 Years Trend
Slightly volatile
   Change To Netincome   
       Timeline  

Cellectis Change To Netincome Regression Statistics

Arithmetic Mean20,725,885
Geometric Mean14,833,283
Coefficient Of Variation96.01
Mean Deviation16,095,975
Median17,275,000
Standard Deviation19,899,830
Sample Variance396T
Range67.9M
R-Value(0.52)
Mean Square Error308.5T
R-Squared0.27
Significance0.04
Slope(2,183,263)
Total Sum of Squares5940T

Cellectis Change To Netincome History

20255.1 M
20245.4 M
2022M
2021-2.8 M
202012.8 M
201914.4 M
201817.3 M

About Cellectis Financial Statements

Cellectis shareholders use historical fundamental indicators, such as Change To Netincome, to determine how well the company is positioned to perform in the future. Although Cellectis investors may analyze each financial statement separately, they are all interrelated. The changes in Cellectis' assets and liabilities, for example, are also reflected in the revenues and expenses on on Cellectis' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Change To Netincome5.4 M5.1 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cellectis Stock Analysis

When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.